Jefferies Group acquired 202k Dianthus Therapeutics shares worth $16.3M. That's 0.19% of their equity portfolio (118th largest holding). The first Dianthus Therapeutics trade was made in Q3 2023. Since then Jefferies Group bought shares one more times and sold shares on two occasions. The stake costed the investor $11.3M, netting the investor a gain of 44% so far.